Synthetic Biology & Health

The seminal achievements of constructing the first synthetic bacterial cell and first minimal cell are key to understanding fundamentals of biology. This work is also expanding the ability to produce various kinds of biologically-based products including new types of medicine and renewable fuels. As the team progresses on their science goals, they are equally focused on the societal implications of this work. Synthetic genomics holds great promise for the future, and our team is at the forefront of discoveries and important public dialogue.

Assembly of HSV-1

Use of cutting-edge synthetic genomics technology to revolutionize the study of herpesvirus biology.

A Synthetic Human Cytomegalovirus Vaccine Platform

Generation of an HCMV low passage clinical isolate using synthetic genomics.

22-Dec-2020
Press Release

Hamilton O. Smith, M.D., Synthetic Biology Pioneer and Nobel Laureate, to Step Down from Daily Duties at J. Craig Venter Institute

Dr. Smith will maintain advisory role as professor emeritus

19-Dec-2020
The San Diego Union-Tribune

After saving countless lives, Nobel laureate Hamilton Smith retires as his own health falters

He has been a fixture in San Diego science for decades

13-Nov-2019
Press Release

J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease

Team targeted specific toxin-producing strains of the bacterium, Enterococcus faecalis, which is shown to be responsible for most liver damage

21-Sep-2018
Collaborator Release

NSF announces new awards for Understanding the Rules of Life

New projects address genetic, environmental causality in biological systems and processes

02-May-2018
Blog

BioVision Alexandria 2018